日本

Biomarker discovery using CyTOF mass cytometry and Imaging Mass Cytometry

By Lindsy Rapkin, PhD, MS, and Connie Inlay, PhD

Field Application Scientist Friday Q&A—Biomarker discovery using CyTOF mass cytometry and Imaging Mass Cytometry

Abstract:

Each unique session will start off with a small vignette of publication spotlights. Following the slide presentation, each session will transition to a discussion of your ideas and questions on a variety of topics:

  • Technology adoption
  • Experimental design
  • Panel design and optimization
  • Comparison to flow cytometry
  • Workflow setup
  • Applications
  • Data analysis

At Fluidigm, we are dedicated to working with you throughout your research and discovery to empower you however we can, whether or not you are our customer.

What to expect from each FAS Friday Q&A session:

Passion: Spending time with you to learn about your research goals, ideas and needs is the foundation of the FAS mass cytometry and Imaging Mass Cytometry™ role.

Expertise: Fluidigm field application scientists highly educated, expertly trained, bench-experienced scientists ready to consult with you during these sessions.

Resourcefulness: Armed with knowledge of CyTOF® mass cytometry and Imaging Mass Cytometry, Fluidigm FAS will share materials, publications and data with you during and following each session.

Education: Increase your knowledge base, learn about a new application and participate in our live Q&A sessions.



About the presenter:

Lindsy Rapkin, PhD
Field Application Specialist
Fluidigm

Connie Inlay

Connie Inlay, PhD
Field Applications Scientist
Fluidigm



For Research Use Only. Not for use in diagnostic procedures.